StockData
Nyxoah SA logo

Nyxoah SA (NYXH) stock

NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$0.86−0.04 (-4.10%)

Close on Nov 18, 2026Market cap $37.13MP/E –Yield –

Nyxoah operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nyxoah's operating cash flow for the twelve months ending Dec 31, 2022 was -€28.76M. For fiscal 2025 it was -€68.98M. The highest annual figure on record is -€5.93M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€68.98M–
FY2024Dec 31, 2024-€49.23M–
FY2023Dec 31, 2023-€44.78M–
FY2022Dec 31, 2022-€28.76M–
FY2021Dec 31, 2021-€25.34M–
FY2020Dec 31, 2020-€6.86M–
FY2019Dec 31, 2019-€5.93M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-€10.37M–
Q3 FY2022Sep 30, 2022-€8.67M–
Q4 FY2021Dec 31, 2021-€7.33M–

More Nyxoah figures

See a number that looks wrong?